Minimal Residual Disease Surveillance in Chronic Lymphocytic Leukemia by Fluorescence-Activated Cell Sorting

Rambam Maimonides Medical Journal - Israel
doi 10.5041/rmmj.10161
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Rambam Health Corporation

Related search

Minimal Residual Disease in Chronic Lymphocytic Leukemia: A New Goal?

Frontiers in Oncology
Cancer ResearchOncology
2019English

Transcend CLL 004: Minimal Residual Disease After Lisocabtagene Maraleucel in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

MicroRNA Expression Profiling Identifies Activated B Cell Status in Chronic Lymphocytic Leukemia Cells

PLoS ONE
Multidisciplinary
2011English

Monitoring of Minimal Residual Disease in Acute Myeloid Leukemia

Cancer
Cancer ResearchOncology
2007English

Allelic Loss Determination in Chronic Lymphocytic Leukemia by Immunomagnetic Bead Sorting and Microsatellite Marker Analysis

Oncogene
Cancer ResearchGeneticsMolecular Biology
1997English

Minimal Residual Disease Quantification by Flow Cytometry Provides Reliable Risk Stratification in T-Cell Acute Lymphoblastic Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2018English

Cytotoxic Lymphocytes in B-Cell Chronic Lymphocytic Leukemia

Annals of Hematology
MedicineHematology
1990English

NOTCH1 Is Aberrantly Activated in Chronic Lymphocytic Leukemia Hematopoietic Stem Cells

Frontiers in Oncology
Cancer ResearchOncology
2018English

Chronic Lymphocytic Leukemia

Current Opinion in Hematology
Hematology
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy